Ernexa Therapeutics Inc.: Form 8-K, filed Jun 9, 2017
Filed with the SEC on Jun 9, 2017 and accepted by EDGAR at Jun 9, 2017, 16:36 ET.
Items reported
- Item 5.03 Amendment to articles or bylaws
- Item 5.07 Shareholder vote results
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001493152-17-006434. Last ingested by Listed: Nov 6, 2026, 17:52 ET. Listed shows no prices and gives no investment advice.